ClinicalTrials.gov
ClinicalTrials.gov Menu

Early Access to Low-dose Ritonavir (TMC114/r) and Other Antiretrovirals (ARVs) for Treatment-naive or Early Treatment Experienced in HIV-1 Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01702090
Recruitment Status : Completed
First Posted : October 5, 2012
Last Update Posted : May 23, 2016
Sponsor:
Information provided by (Responsible Party):
Janssen-Cilag Ltd.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : June 2012
  Actual Study Completion Date : June 2012